2024-12-29 02:06:27
Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome
Health/ 2023-07-22
Cellenkos(R) Inc. Announces FDA Clearanc...

HOUSTON,June 2,2020-- Cellenkos Inc.,a privately held,clinical stage biotech company announced today that the US Food & Drug Administrat...

The 2nd Singapore-China Joint Meeting on COVID-19
Health/ 2023-07-22
The 2nd Singapore-China Joint Meeting on...

Joint Press Statement SINGAPORE,May 30,2020-- On 28 May 2020,Permanent Secretary Chee Wee Kiong of the Ministry of Foreign Affairs of the Re...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release